-
Je něco špatně v tomto záznamu ?
A multiparametric heart failure score at baseline is associated with long-term outcome in patients with remotely monitored implantable cardioverter-defibrillators: A pooled analysis of 9 clinical trials
A. D'Onofrio, F. Solimene, A. Bulava, M. Shoda, C. Klein, A. Gargaro, T. Timmel, D. Giacopelli, G. Botto
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- algoritmy MeSH
- časové faktory MeSH
- defibrilátory implantabilní * MeSH
- klinické zkoušky jako téma MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- senioři MeSH
- srdeční selhání * terapie patofyziologie mortalita MeSH
- technologie dálkového snímání metody MeSH
- tepový objem fyziologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: To predict worsening heart failure hospitalizations (WHFHs), the HeartInsight multiparametric algorithm calculates a heart failure (HF) Score based on temporal trends of physiologic parameters obtained through automatic daily remote monitoring of implantable cardioverter-defibrillators (ICDs). OBJECTIVE: We studied the association of the baseline HF Score, determined at algorithm activation, with long-term patient outcomes. METHODS: Data from 9 clinical trials were pooled, including 1841 ICD patients with a preimplantation ejection fraction ≤35%, New York Heart Association class II/III, and no long-standing atrial fibrillation. The primary end point was a composite of death or WHFH. RESULTS: After a median follow-up of 631 days (interquartile range, 385-865 days), there were 243 WHFHs in 173 patients (9.4%) and 122 deaths (6.6%), 52 of which (42.6%) were cardiovascular. The primary end point occurred in 265 patients (14.4%). A multivariable time-to-first-event analysis showed that a high baseline HF Score (>23, as determined by a time-dependent receiver operating characteristics curve analysis) was significantly associated with the occurrence of the primary end point (adjusted hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.54-2.71; P < .0001), all-cause death (HR, 2.37; CI, 1.56-3.58; P < .0001), cardiovascular death (HR, 2.19; CI, 1.14-4.22; P = .019), and WHFH (HR, 1.91; CI, 1.35-2.71; P = .0003). In a hierarchical event analysis of all-cause death as the outcome with highest priority and WHFHs as repeated event outcomes, the win ratio was 2.47 (CI, 1.89-3.24; P < .0001). CONCLUSION: Based on a retrospective analysis of clinical trial data with adjudicated events, baseline HF Score derived from device-monitored variables was able to stratify patients at higher long-term risk of death or WHFH.
Center for Clinical Research Biotronik SE and Co KG Berlin Germany
Clinical Unit Biotronik Italia S p a Cologno Monzese Italy
Electrophysiology Montevergine Clinic Mercogliano Italy
U O Electrophysiology ASST Rhodense Garbagnate Milanese Italy
Unità Operativa di Elettrofisiologia Studio e Terapia delle Aritmie Monaldi Hospital Naples Italy
University of Lille CHU Lille Lille University Hospital Center Lille Hauts de France France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009399
- 003
- CZ-PrNML
- 005
- 20250429135119.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.hrthm.2024.10.005 $2 doi
- 035 __
- $a (PubMed)39383980
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a D'Onofrio, Antonio $u Unità Operativa di Elettrofisiologia, Studio e Terapia delle Aritmie, Monaldi Hospital, Naples, Italy. Electronic address: donofrioant1@gmail.com
- 245 12
- $a A multiparametric heart failure score at baseline is associated with long-term outcome in patients with remotely monitored implantable cardioverter-defibrillators: A pooled analysis of 9 clinical trials / $c A. D'Onofrio, F. Solimene, A. Bulava, M. Shoda, C. Klein, A. Gargaro, T. Timmel, D. Giacopelli, G. Botto
- 520 9_
- $a BACKGROUND: To predict worsening heart failure hospitalizations (WHFHs), the HeartInsight multiparametric algorithm calculates a heart failure (HF) Score based on temporal trends of physiologic parameters obtained through automatic daily remote monitoring of implantable cardioverter-defibrillators (ICDs). OBJECTIVE: We studied the association of the baseline HF Score, determined at algorithm activation, with long-term patient outcomes. METHODS: Data from 9 clinical trials were pooled, including 1841 ICD patients with a preimplantation ejection fraction ≤35%, New York Heart Association class II/III, and no long-standing atrial fibrillation. The primary end point was a composite of death or WHFH. RESULTS: After a median follow-up of 631 days (interquartile range, 385-865 days), there were 243 WHFHs in 173 patients (9.4%) and 122 deaths (6.6%), 52 of which (42.6%) were cardiovascular. The primary end point occurred in 265 patients (14.4%). A multivariable time-to-first-event analysis showed that a high baseline HF Score (>23, as determined by a time-dependent receiver operating characteristics curve analysis) was significantly associated with the occurrence of the primary end point (adjusted hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.54-2.71; P < .0001), all-cause death (HR, 2.37; CI, 1.56-3.58; P < .0001), cardiovascular death (HR, 2.19; CI, 1.14-4.22; P = .019), and WHFH (HR, 1.91; CI, 1.35-2.71; P = .0003). In a hierarchical event analysis of all-cause death as the outcome with highest priority and WHFHs as repeated event outcomes, the win ratio was 2.47 (CI, 1.89-3.24; P < .0001). CONCLUSION: Based on a retrospective analysis of clinical trial data with adjudicated events, baseline HF Score derived from device-monitored variables was able to stratify patients at higher long-term risk of death or WHFH.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a defibrilátory implantabilní $7 D017147
- 650 12
- $a srdeční selhání $x terapie $x patofyziologie $x mortalita $7 D006333
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a klinické zkoušky jako téma $7 D002986
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a algoritmy $7 D000465
- 650 _2
- $a technologie dálkového snímání $x metody $7 D058998
- 650 _2
- $a tepový objem $x fyziologie $7 D013318
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Solimene, Francesco $u Electrophysiology, Montevergine Clinic, Mercogliano, Italy
- 700 1_
- $a Bulava, Alan $u Ceske Budejovice Hospital, Faculty of Health and Social Sciences, University of South Bohemia in Ceske Budejovice, Ceske Budejovice, Czech Republic
- 700 1_
- $a Shoda, Morio $u Clinical Research Division for Heart Rhythm Management, Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan
- 700 1_
- $a Klein, Cedric $u University of Lille, CHU Lille, Lille University Hospital Center, Lille, Hauts-de-France, France
- 700 1_
- $a Gargaro, Alessio $u Clinical Unit, Biotronik Italia S.p.a., Cologno Monzese (MI), Italy
- 700 1_
- $a Timmel, Tobias $u Center for Clinical Research, Biotronik SE & Co KG, Berlin, Germany
- 700 1_
- $a Giacopelli, Daniele $u Clinical Unit, Biotronik Italia S.p.a., Cologno Monzese (MI), Italy
- 700 1_
- $a Botto, Gianluca $u U.O. Electrophysiology, ASST Rhodense, Garbagnate Milanese (MI), Italy
- 773 0_
- $w MED00156180 $t Heart rhythm $x 1556-3871 $g Roč. 22, č. 4 (2025), s. 1055-1063
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39383980 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135115 $b ABA008
- 999 __
- $a ok $b bmc $g 2311027 $s 1246480
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 22 $c 4 $d 1055-1063 $e 20241009 $i 1556-3871 $m Heart rhythm $n Heart Rhythm $x MED00156180
- LZP __
- $a Pubmed-20250415